Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Puhua International Hospital is a private international hospital in Beijing, China focused on specialty and high-acuity care, particularly in neurology, neurosurgery, oncology, orthopedics, rehabilitation, and traditional Chinese medicine. The hospital presents itself as a high-end medical institution serving both domestic and international patients and operates as part of the APM Group. Its marketed capabilities emphasize advanced clinical interventions such as spinal cord reconstruction surgery with neural growth factor therapy, robot-assisted stereotactic brain surgery, and magnetic resonance-guided focused ultrasound. Rather than a drug-development biotech company, it is a care delivery organization offering hospital-based diagnosis, surgery, rehabilitation, and related medical services. The institution appears to be active and commercially operating, with a particular brand focus on complex neurological care and medical tourism/international patient services.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Puhua International Hospital.